Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Cyclin-Dependent Kinases

Items 21-30 of 65

Page
per page
  1. LDC000067
    B4754 LDC000067
     2 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK9 inhibitor, novel and highly specific
      insoluble in H2O; insoluble in EtOH; ≥18.52 mg/mL
  2. THZ1 Hydrochloride
    B4736 THZ1 Hydrochloride
    Target: Cyclin-Dependent Kinases
    Summary: CDK7 inhibitor
      ≥30.13 mg/mL
  3. ML167
    B3707 ML167
    Target: Clk
    Summary: Clk4 inhibitor,highly selective
      insoluble in EtOH; insoluble in H2O; ≥16.75 mg/mL
  4. AMG 925
    B3277 AMG 925
    Target: Cyclin-Dependent Kinases|FLT3
    Summary: FLT3/CDK4 inhibitor,potent and selective
      insoluble in DMSO; insoluble in H2O; insoluble in EtOH
  5. LEE011 succinate
    B1084 LEE011 succinate
    Summary: CDK inhibitor
      Soluble in DMSO
  6. LEE011 hydrochloride
    B1083 LEE011 hydrochloride
    Summary: CDK inhibitor
      Soluble in DMSO
  7. Ro 3306
    A8885 Ro 3306
     23 Citation
    Target: Cyclin-Dependent Kinases
    Summary: CDK1 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.39 mg/mL
  8. THZ1
    A8882 THZ1
     12 Citation
    Target: Cyclin-Dependent Kinases
    Summary: Covalent CDK7 inhibitor,potent and selective
      ≥28.3 mg/mL
  9. CCT251545 analogue
    A8739 CCT251545 analogue
    Summary: Potent, Selective, orally bioavailable CDK 8/19 Inhibitor
      ≥20.7 mg/mL
  10. THZ531
    A8736 THZ531
    Target: Cyclin-Dependent Kinases
    Summary: CDK12 and CDK13 covalent inhibitor
      ≥55.8 mg/mL

Items 21-30 of 65

Page
per page